{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:09:51Z","timestamp":1794038991777,"version":"4.8.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.drudis.2024.104013","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T16:30:55Z","timestamp":1714753855000},"page":"104013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thyroid receptor \u03b2: A promising target for developing novel anti-androgenetic alopecia drugs"],"prefix":"10.1016","volume":"29","author":[{"given":"Jia","family":"Zhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3511-5794","authenticated-orcid":false,"given":"Renren","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.104013_b0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jdv.12034","article-title":"Guidelines for management of androgenetic alopecia based on BASP classification\u2013the Asian consensus committee guideline","volume":"27","author":"Lee","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.drudis.2024.104013_b0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2133.2010.09640.x","article-title":"Prevalence of androgenetic alopecia in China: a community-based study in six cities: Prevalence of androgenetic alopecia in China","volume":"162","author":"Wang","year":"2010","journal-title":"Brit J Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"Devjani","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2024.104013_b0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14656566.2020.1721463","article-title":"A review of the treatment of male pattern hair loss","volume":"21","author":"York","year":"2020","journal-title":"Expert Opin Pharmaco"},{"key":"10.1016\/j.drudis.2024.104013_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","article-title":"Androgenetic alopecia: a review","volume":"57","author":"Lolli","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.drudis.2024.104013_b0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaad.2019.09.013","article-title":"Pattern hair loss: assessment of inflammation and fibrosis on histologic sections","volume":"82","author":"Valdebran","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-019-00479-x","article-title":"Female androgenetic alopecia: an update on diagnosis and management","volume":"21","author":"Starace","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0040","first-page":"613","article-title":"Androgenetic alopecia: an update","volume":"79","author":"Kaliyadan","year":"2013","journal-title":"Indian J Dermatol Ve"},{"key":"10.1016\/j.drudis.2024.104013_b0045","first-page":"263","article-title":"Genetic and molecular aspects of androgenetic alopecia","volume":"84","author":"Martinez-Jacobo","year":"2018","journal-title":"Indian J Dermatol Ve"},{"key":"10.1016\/j.drudis.2024.104013_b0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0531-5565(02)00093-1","article-title":"Molecular mechanisms of androgenetic alopecia","volume":"37","author":"Tr\u00fceb","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.drudis.2024.104013_b0055","first-page":"1001","article-title":"Stress and the hair growth cycle: cortisol-induced hair growth disruption","volume":"15","author":"Thom","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0060","first-page":"125","article-title":"Seborrheic dermatitis: an overview","volume":"74","author":"Schwartz","year":"2006","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.drudis.2024.104013_b0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ecl.2007.03.004","article-title":"Androgenetic alopecia","volume":"36","author":"Otberg","year":"2007","journal-title":"Endocrin Metab Clin North Am"},{"key":"10.1016\/j.drudis.2024.104013_b0070","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-12-0455","article-title":"Testosterone: a metabolic hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.drudis.2024.104013_b0075","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1524-6175.2001.00455.x","article-title":"Direct vasodilators and their role in hypertension management: minoxidil","volume":"3","author":"Sica","year":"2001","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.drudis.2024.104013_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi","year":"2012","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1016\/j.drudis.2024.104013_b0090","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.drudis.2024.104013_b0095","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1610-0379.2011.07802.x","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men","volume":"9","author":"Blumeyer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.drudis.2024.104013_b0100","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1080\/09546634.2021.1959506","article-title":"Finasteride for hair loss: a review","volume":"33","author":"Gupta","year":"2022","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.drudis.2024.104013_b0105","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archdermatol.2010.256","article-title":"Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review","volume":"146","author":"Mella","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0110","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1743-6109.2010.02157.x","article-title":"Adverse side effects of 5\u03b1-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients","volume":"8","author":"Traish","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.drudis.2024.104013_b0115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/DDDT.S240615","article-title":"Finasteride and its potential for the treatment of female pattern hair loss: evidence to date","volume":"14","author":"Iamsumang","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.drudis.2024.104013_b0125","doi-asserted-by":"crossref","first-page":"e19486","DOI":"10.1097\/MD.0000000000019486","article-title":"Association of finasteride with prostate cancer: a systematic review and meta-analysis","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (baltimore)"},{"key":"10.1016\/j.drudis.2024.104013_b0130","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.bbagen.2012.06.003","article-title":"Thyroid hormone receptors: the challenge of elucidating isotype-specific functions and cell-specific response","volume":"1830","author":"Flamant","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2024.104013_b0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.drudis.2024.104013_b0140","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2826.2008.01733.x","article-title":"Neurodevelopmental and neurophysiological actions of thyroid hormone","volume":"20","author":"Williams","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.drudis.2024.104013_b0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0083-6729(05)71004-9","article-title":"Thyroid hormones and brain development","volume":"71","author":"Bernal","year":"2005","journal-title":"Vitam Horm"},{"key":"10.1016\/j.drudis.2024.104013_b0150","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1210\/me.2010-0175","article-title":"The thyroid hormone receptor \u03b11 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons","volume":"24","author":"Wallis","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.drudis.2024.104013_b0155","first-page":"2115","article-title":"Ablation of TR 2 and a concomitant overexpression of 1 yields a mixed hypo- and hyperthyroid phenotype in mice","volume":"15","author":"Salto","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.drudis.2024.104013_b0160","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/MCB.21.14.4761-4772.2001","article-title":"Functional Interference between thyroid hormone receptor \u03b1 (TR\u03b1) and natural truncated TR\u0394\u03b1 isoforms in the control of intestine development","volume":"21","author":"Plateroti","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.104013_b0165","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1073\/pnas.062413299","article-title":"Deletion of the thyroid hormone receptor \u03b11 prevents the structural alterations of the cerebellum induced by hypothyroidism","volume":"99","author":"Morte","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2024.104013_b0170","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1242\/dev.01648","article-title":"Thyroid hormone T3 acting through the thyroid hormone \u03b1 receptor is necessary for implementation of erythropoiesis in the neonatal spleen environment in the mouse","volume":"132","author":"Angelin-Duclos","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.drudis.2024.104013_b0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1043-2760(03)00144-9","article-title":"The molecular actions of thyroid hormone in bone","volume":"14","author":"Bassett","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.drudis.2024.104013_b0180","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/pr.58.4.3","article-title":"International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors","volume":"58","author":"Flamant","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.drudis.2024.104013_b0185","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1172\/JCI10858","article-title":"Critical role for thyroid hormone receptor \u03b22 in the regulation of paraventricular thyrotropin-releasing hormone neurons","volume":"107","author":"Abel","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2024.104013_b0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/83829","article-title":"A thyroid hormone receptor that is required for the development of green cone photoreceptors","volume":"27","author":"Ng","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.drudis.2024.104013_b0195","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ncpendmet0424","article-title":"Thyroid hormone receptors in brain development and function","volume":"3","author":"Bernal","year":"2007","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.drudis.2024.104013_b0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.2001.81.1.449","article-title":"Controls of hair follicle cycling","volume":"81","author":"Stenn","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.drudis.2024.104013_b0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.sder.2006.01.002","article-title":"Biology of the hair follicle: the basics","volume":"25","author":"Krause","year":"2006","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.drudis.2024.104013_b0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1242\/jcs.02793","article-title":"The hair cycle","volume":"119","author":"Alonso","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.drudis.2024.104013_b0215","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.bbagen.2012.03.012","article-title":"Thyroid hormone receptors, cell growth and differentiation","volume":"1830","author":"Pascual","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2024.104013_b0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128071-200304050-00003","article-title":"Cutaneous manifestations of endocrine disorders: a guide for dermatologists","volume":"4","author":"Jabbour","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0225","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2133.2000.03408.x","article-title":"Thyroid hormone receptor \u03b21 is expressed in the human hair follicle: THYROID HORMONE RECEPTOR \u03b21 IN HUMAN HAIR","volume":"142","author":"Billoni","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0230","doi-asserted-by":"crossref","first-page":"e108137","DOI":"10.1371\/journal.pone.0108137","article-title":"Impaired hair growth and wound healing in mice lacking thyroid hormone receptors","volume":"9","author":"Contreras-Jurado","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.drudis.2024.104013_b0235","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2024.104013_b0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jdermsci.2003.12.003","article-title":"Role of TGF-\u03b22 in the human hair cycle","volume":"35","author":"Hibino","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.drudis.2024.104013_b0245","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1523-1747.2002.01746.x","article-title":"Involvement of transforming growth factor-\u03b22 in catagen induction during the human hair cycle","volume":"118","author":"Soma","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0250","first-page":"138","article-title":"Investigating the roles of cellular senescence in embryogenesis and aging, Thesis","author":"Mekayla","year":"2014","journal-title":"Universitat Pompeu Fabra"},{"key":"10.1016\/j.drudis.2024.104013_b0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2004.11.002","article-title":"Dual role for TGF-beta1 in apoptosis","volume":"16","author":"Sanchezcapelo","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.drudis.2024.104013_b0260","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1096\/fasebj.14.5.752","article-title":"Control of murine hair follicle regression (catagen) by TGF-\u03b21 in vivo","volume":"14","author":"Foitzik","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2024.104013_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.933370","article-title":"Hair follicle morphogenesis during embryogenesis, neogenesis, and organogenesis","volume":"10","author":"Park","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2024.104013_b0270","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1210\/jc.2008-0283","article-title":"Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation","volume":"93","author":"Van Beek","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.drudis.2024.104013_b0275","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/CCID.S354219","article-title":"Thyroid hormone receptor agonist promotes hair growth in mice","volume":"15","author":"Zhu","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0280","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1242\/dev.02278","article-title":"NF-\u03baB transmits Eda A1\/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth","volume":"133","author":"Schmidt-Ullrich","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.drudis.2024.104013_b0285","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/bjd.18356","article-title":"Deciphering the molecular morphology of the human hair cycle: wnt signalling during the telogen\u2013anagen transformation","volume":"182","author":"Hawkshaw","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0290","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0002-9440(10)63456-6","article-title":"Differential expression of cyclin D1 in the human hair follicle","volume":"163","author":"Xu","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.drudis.2024.104013_b0295","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.0022-202X.2005.23867.x","article-title":"Modulation of hair growth with small molecule agonists of the hedgehog signaling pathway","volume":"125","author":"Paladini","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0300","doi-asserted-by":"crossref","first-page":"14466","DOI":"10.1073\/pnas.0706754104","article-title":"Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes","volume":"104","author":"Dentice","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2024.104013_b0305","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrm2636","article-title":"Epidermal homeostasis: a balancing act of stem cells in the skin","volume":"10","author":"Blanpain","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.104013_b0310","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/exd.14251","article-title":"Stem cell-intrinsic mechanisms regulating adult hair follicle homeostasis","volume":"30","author":"Lee","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0315","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1091\/mbc.E14-07-1251","article-title":"Thyroid hormone signaling controls hair follicle stem cell function","volume":"26","author":"Contreras-Jurado","year":"2015","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.drudis.2024.104013_b0320","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1634\/stemcells.2005-0544","article-title":"Bone morphogenetic protein signaling inhibits hair follicle anagen induction by restricting epithelial stem\/progenitor cell activation and expansion","volume":"24","author":"Zhang","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2024.104013_b0325","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.1073\/pnas.0703004104","article-title":"Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling","volume":"104","author":"Kobielak","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2024.104013_b0330","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1096\/fj.04-2079rev","article-title":"The cutaneous serotoninergic\/melatoninergic system: securing a place under the sun","volume":"19","author":"Slominski","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2024.104013_b0335","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0531-5565(00)00210-2","article-title":"Graying: gerontobiology of the hair follicle pigmentary unit","volume":"36","author":"Tobin","year":"2001","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.drudis.2024.104013_b0340","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: biology and development","volume":"1","author":"Cichorek","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.drudis.2024.104013_b0345","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.0022-202X.2005.23959.x","article-title":"Changes in different melanocyte populations during hair follicle involution (Catagen)","volume":"125","author":"Sharov","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.0022-202X.2004.23528.x","article-title":"Hair follicle pigmentation","volume":"124","author":"Slominski","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00059.2017","article-title":"Melanosomes: biogenesis, properties, and evolution of an ancient organelle","volume":"99","author":"D\u2019Alba","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.drudis.2024.104013_b0360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1475-2859-12-108","article-title":"Metabolic engineering of Escherichia coli to optimize melanin synthesis from glucose","volume":"12","author":"Chavez-Bejar","year":"2013","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.drudis.2024.104013_b0365","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1242\/jcs.115.7.1441","article-title":"Filopodia are conduits for melanosome transfer to keratinocytes","volume":"115","author":"Scott","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.drudis.2024.104013_b0370","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bmcl.2009.10.109","article-title":"Thyroid receptor agonists for the treatment of androgenetic alopecia","volume":"20","author":"Li","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104013_b0375","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jid.2016.03.033","article-title":"The thyroid hormone analogue KB2115 (Eprotirome) prolongs human hair growth (Anagen) ex vivo","volume":"136","author":"Ol\u00e1h","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2024.104013_b0380","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/jm021080f","article-title":"Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1","volume":"46","author":"Ye","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.104013_b0385","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1527-3466.2005.tb00161.x","article-title":"Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects","volume":"23","author":"Grover","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.drudis.2024.104013_b0390","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.bmcl.2004.04.032","article-title":"Thyroid receptor ligands. Part 2: thyromimetics with improved selectivity for the thyroid hormone receptor beta","volume":"14","author":"Hangeland","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104013_b0395","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bmcl.2005.11.002","article-title":"Thyroid receptor ligands. Part 4: 4\u2032-amido bioisosteric ligands selective for the thyroid hormone receptor beta","volume":"16","author":"Li","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104013_b0400","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1021\/jm4019299","volume":"57","author":"Kelly","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.104013_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/4950597","article-title":"CS27109, A selective thyroid hormone receptor-\u03b2 agonist alleviates metabolic-associated fatty liver disease in murine models","volume":"2023","author":"Huang","year":"2023","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.drudis.2024.104013_b0410","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/acs.jmedchem.2c01669","article-title":"Discovery of highly potent and selective thyroid hormone receptor \u03b2 agonists for the treatment of nonalcoholic steatohepatitis","volume":"66","author":"Hu","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.104013_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127465","article-title":"Selective thyroid hormone receptor \u03b2 agonists with oxadiazolone acid isosteres","volume":"30","author":"Kirschberg","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104013_b0420","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1248\/bpb.b13-00915","article-title":"In vivo evaluation of 1-Benzyl-4-aminoindole-based thyroid hormone receptor \u03b2 agonists: importance of liver selectivity in drug discovery","volume":"37","author":"Takahashi","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.drudis.2024.104013_b0425","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1074-5521(98)90168-5","article-title":"A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor","volume":"5","author":"Chiellini","year":"1998","journal-title":"Chem Biol"},{"key":"10.1016\/j.drudis.2024.104013_b0430","doi-asserted-by":"crossref","first-page":"15358","DOI":"10.1073\/pnas.2136689100","article-title":"Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor","volume":"100","author":"Borngraeber","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2024.104013_b0435","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jsb.2010.10.003","article-title":"The binding of synthetic triiodo l-thyronine analogs to human transthyretin: Molecular basis of cooperative and non-cooperative ligand recognition","volume":"173","author":"Trivella","year":"2011","journal-title":"J Struct Biol"},{"key":"10.1016\/j.drudis.2024.104013_b0440","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/ja003442j","article-title":"A subtype-selective thyromimetic designed to bind a mutant thyroid hormone receptor implicated in resistance to thyroid hormone","volume":"123","author":"Ye","year":"2001","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2024.104013_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112006","article-title":"Design, synthesis and biological evaluation of novel TR\u03b2 selective agonists sustained by ADME-toxicity analysis","volume":"188","author":"Runfola","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2024.104013_b0450","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/378690a0","article-title":"A structural role for hormone in the thyroid hormone receptor","volume":"378","author":"Wagner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104013_b0455","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0960-894X(02)00947-2","article-title":"Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR\u03b2 subtype-selective thyromimetics","volume":"13","author":"Dow","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104013_b0460","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bmcl.2005.02.028","article-title":"Novel heterocyclic thyromimetics","volume":"15","author":"Haning","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104013_b0465","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bmc.2012.12.002","article-title":"Design, synthesis, and structure\u2013activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor \u03b2 (TR\u03b2) selective agonists","volume":"21","author":"Shiohara","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2024.104013_b0470","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bmcl.2005.11.077","article-title":"Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor \u03b2","volume":"16","author":"Garcia Collazo","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2024.104013_b0475","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1073\/pnas.0702759104","article-title":"Targeting thyroid hormone receptor-\u03b2 agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index","volume":"104","author":"Erion","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2024.104013_b0480","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1021\/jm800824d","article-title":"Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs","volume":"51","author":"Boyer","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.104013_b0485","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.isci.2019.10.002","article-title":"Revealing a mutant-induced receptor allosteric mechanism for the thyroid hormone resistance","volume":"20","author":"Yao","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.drudis.2024.104013_b0490","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","article-title":"Roxadustat: first global approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2024.104013_b0495","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1021\/acs.jmedchem.2c00144","article-title":"Discovery of a highly selective and H435R-sensitive thyroid hormone receptor \u03b2 agonist","volume":"65","author":"Li","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.104013_b0500","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/j.bmcl.2005.06.093","article-title":"A new class of high affinity thyromimetics containing a phenyl-naphthylene core","volume":"15","author":"Hangeland","year":"2005","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T02:33:11Z","timestamp":1716604391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624001387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1359644624001387"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104013","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid receptor \u03b2: A promising target for developing novel anti-androgenetic alopecia drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104013"}}